Gastrointestinal inflammation: Lessons from metabolic modulators

Journal of Internal Medicine

Volumn 263, Issue 6, 2008, Pages 607-612

  Arulampalam, V ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Gastroenterology; Inflammation; Nuclear receptors

Indexed keywords

CELL NUCLEUS RECEPTOR; FATTY ACID; LIPOPOLYSACCHARIDE; LIVER RECEPTOR HOMOLOG 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE A2; TOLL LIKE RECEPTOR 4; XENOBIOTIC AGENT;

CELL DIFFERENTIATION; CELL INFILTRATION; CONFERENCE PAPER; CROHN DISEASE; DIGESTIVE SYSTEM INFLAMMATION; ENERGY METABOLISM; HUMAN; IMMUNOMODULATION; INSULIN RESISTANCE; LIPID METABOLISM; MACROPHAGE; METABOLIC DISORDER; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; LIPID METABOLISM; MACROPHAGES; PPAR GAMMA; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 43549084337     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01964.x     Document Type: Conference Paper

References (31)

1. Wu GD. Nuclear hormone receptors and intestinal inflammation. Gastroenterology 2007 133 : 1068.
2. Zhou C, Tabb MM, Nelson EL et al. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest 2006 116 : 2280 9.
3. Szatmari I, Pap A, Ruhl R et al. PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J Exp Med 2006 203 : 2351 62.
4. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000 18 : 767 811.
5. Lindemann S, Kramer B, Seizer P, Gawaz M. Platelets, inflammation and atherosclerosis. J Thromb Haemost 2007 5 (Suppl. 1 203 11.
6. Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat Med 2002 8 : 1235 42.
7. Swirski FK, Libby P, Aikawa E et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata [see comment]. J Clin Invest 2007 117 : 195 205.
8. Tacke F, Alvarez D, Kaplan TJ et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques [see comment]. J Clin Invest 2007 117 : 185 94.
9. Bouhlel MA, Derudas B, Rigamonti E et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties [see comment]. Cell Metabolism 2007 6 : 137 43.
10. Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, Glass CK. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice [see comment]. J Clin Invest 2000 106 : 523 31.
11. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006 444 : 860 7.
12. Hevener AL, Olefsky JM, Reichart D et al. Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest 2007 117 : 1658 69.
13. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007 447 : 1116 20.
14. Backhed F, Ding H, Wang T et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004 101 : 15718 23.
15. Kersten S, Mandard S, Tan NS et al. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem 2000 275 : 28488 93.
16. Are A, Aronsson L, Wang S et al. Enterococcus faecalis from newborn babies regulate peroxisome proliferator activated receptor-gamma activity and IL-10 secretion in colonic epithelial cells. Proc Natl Acad Sci U S A 2008 105 : 1943 8.
17. Backhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 2007 104 : 979 84.
18. Ziouzenkova O, Perrey S, Asatryan L et al. Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase. Proc Natl Acad Sci U S A 2003 100 : 2730 5.
19. Qi HY, Shelhamer JH. Toll-like receptor 4 signaling regulates cytosolic phospholipase A2 activation and lipid generation in lipopolysaccharide- stimulated macrophages. J Biol Chem 2005 280 : 38969 75.
20. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006 116 : 3015 25.
21. Nguyen MT, Favelyukis S, Nguyen AK et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 2007 382 : 35279 92.
22. Ogawa S, Lozach J, Benner C et al. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 2005 122 : 707 21.
23. Dubuquoy L, Rousseaux C, Thuru X et al. PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut 2006 55 : 1341 9.
24. Kelly D, Campbell JI, King TP et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR- gamma and RelA. Nat Immunol 2004 5 : 104 12.
25. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors [see comment]. Nat Med 2003 9 : 213 9.
26. Castrillo A, Joseph SB, Vaidya SA et al. Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 2003 12 : 805 16.
27. Joseph SB, Bradley MN, Castrillo A et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response [see comment]. Cell 2004 119 : 299 309.
28. Valledor AF, Hsu LC, Ogawa S, Sawka-Verhelle D, Karin M, Glass CK. Activation of liver X receptors and retinoid X receptors prevents bacterial- induced macrophage apoptosis. Proc Natl Acad Sci U S A 2004 101 : 17813 8.
29. Shah YM, Ma X, Morimura K, Kim I, Gonzalez FJ. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression. Am J Physiol Gastrointest Liver Physiol 2007 292 : G1114 22.
30. Coste A, Dubuquoy L, Barnouin R et al. LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease. Proc Natl Acad Sci U S A 2007 104 : 13098 103.
31. Lundin A, Bok CM, Aronsson L et al. Gut flora, Toll-like receptors and nuclear receptors: a tripartite communication that tunes innate immunity in large intestine. Cell Microbiol 2008 doi :.